Akari Therapeutics Ownership | Who Owns Akari Therapeutics?
Akari Therapeutics Ownership Summary
Akari Therapeutics is owned by 0.02% institutional investors, 24.56% insiders, and 75.42% retail investors. Sabby management is the largest institutional shareholder, holding 32.93% of AKTX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Akari Therapeutics shares.
AKTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Akari Therapeutics | 0.02% | 24.56% | 75.42% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Sabby management | 179.78K | 32.93% | $210.33K |
| Newedge advisors | 6.80K | 1.25% | $7.96K |
| Eversource wealth advisors | 44.00 | 0.28% | $44.00 |
| Ifp advisors | 181.00 | - | $932.00 |
| Truvestments capital | - | - | - |
| Palo alto investors lp | - | - | - |
| Jane street group | - | - | - |
| Omnia family wealth | - | - | - |
| Cwa asset management group | - | - | - |
| Hightower advisors | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sabby management | 179.78K | 0.38% | $210.33K |
| Ifp advisors | 181.00 | - | $932.00 |
| Hightower advisors | - | - | - |
| Jane street group | - | - | - |
| Truvestments capital | - | - | - |
| Palo alto investors lp | - | - | - |
| Eversource wealth advisors | 44.00 | - | $44.00 |
| Omnia family wealth | - | - | - |
| Cwa asset management group | - | - | - |
| Accent capital management | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sabby management | 179.78K | 0.38% | 179.78K |
| Newedge advisors | 6.80K | - | 6.80K |
| Ifp advisors | 181.00 | - | 181.00 |
| Morgan stanley | - | - | -3.00 |
| Cornerstone planning group | - | - | -5.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -2.72M |
| Cresset asset management | - | - | -822.47K |
| Warberg asset management | - | - | -308.34K |
| Palo alto investors lp | - | - | -146.02K |
| Hightower advisors | - | - | -79.24K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sabby management | 179.78K | 0.38% | 179.78K | $210.33K |
| Newedge advisors | 6.80K | - | 6.80K | $7.96K |
| Ifp advisors | 181.00 | - | 181.00 | $932.00 |
Sold Out
| Holder | Change |
|---|---|
| Morgan stanley | -3.00 |
| Cornerstone planning group | -5.00 |
| Truvestments capital | -50.00 |
| Sbi securities | -200.00 |
| Accent capital management | -5.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 3 | -85.71% | 7,256 | -99.84% | - | 0.01% | 1 | -91.67% | 2 | - |
| Dec 31, 2025 | 14 | -12.50% | 683,594 | -41.58% | 209,286 | 0.00% | 8 | 60.00% | 2 | -33.33% |
| Sep 30, 2025 | 16 | 14.29% | 1,170,067 | 112.45% | 7,435 | 73.05% | 6 | 20.00% | 3 | 50.00% |
| Jun 30, 2025 | 15 | 50.00% | 550,740 | 80.99% | 100 | 32469.88% | 5 | - | 3 | 200.00% |
| Mar 31, 2025 | 10 | -28.57% | 304,298 | -5.73% | - | 30.53% | - | -100.00% | 1 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Nasdaq Composite Index | 1.51K | 0.01% | - |
| RiverNorth Marketplace Lending Corp | 1.10K | 0.00% | - |
| RiverNorth Opportunities | 509.00 | 0.00% | - |
| LUX IM Global Medtech HX | 1.00 | 0.00% | -63.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 16, 2025 | Neal James R | - | Buy | $960.27 |
| Dec 16, 2025 | Neal James R | - | Buy | - |
| Dec 16, 2025 | Neal James R | - | Buy | $1.20K |
| Dec 16, 2025 | Neal James R | - | Buy | - |
| Dec 16, 2025 | Prudo-Chlebosz Raymond | - | Buy | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | 3 | - |
| 2025 Q2 | 4 | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
AKTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools